FUSION PHARMACEUTICALS INC's ticker is FUSN and the CUSIP is 36118A100. A total of 41 filers reported holding FUSION PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,485 | -44.3% | 1,725,000 | 0.0% | 0.19% | -23.2% |
| Q2 2023 | $8,056 | +8.2% | 1,725,000 | -12.7% | 0.25% | -43.4% |
| Q1 2023 | $7,446 | +215.1% | 1,975,000 | +163.3% | 0.44% | +234.8% |
| Q4 2022 | $2,363 | -99.9% | 750,000 | 0.0% | 0.13% | +37.5% |
| Q3 2022 | $2,258,000 | +20.9% | 750,000 | 0.0% | 0.10% | -4.0% |
| Q2 2022 | $1,868,000 | -67.9% | 750,000 | 0.0% | 0.10% | -59.0% |
| Q1 2022 | $5,828,000 | +86.3% | 750,000 | 0.0% | 0.24% | +187.1% |
| Q4 2021 | $3,128,000 | -47.3% | 750,000 | 0.0% | 0.08% | -36.1% |
| Q3 2021 | $5,940,000 | -2.0% | 750,000 | 0.0% | 0.13% | +8.1% |
| Q2 2021 | $6,060,000 | +4.8% | 750,000 | +39.1% | 0.12% | +20.6% |
| Q1 2021 | $5,781,000 | – | 539,264 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,670,516 | $9,140,000 | 2.34% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,560,982 | $3,887,000 | 1.96% |
| ADAMS STREET PARTNERS LLC | 2,947,809 | $7,340,000 | 1.91% |
| Sio Capital Management, LLC | 260,448 | $649,000 | 0.24% |
| Orbimed Advisors | 3,224,770 | $8,030,000 | 0.15% |
| Artal Group S.A. | 750,000 | $1,868,000 | 0.10% |
| TPG GP A, LLC | 2,551,794 | $6,354,000 | 0.10% |
| Perceptive Advisors | 1,052,445 | $2,621,000 | 0.08% |
| Rock Springs Capital Management LP | 809,854 | $2,017,000 | 0.06% |
| FEDERATED HERMES, INC. | 3,124,100 | $7,779,000 | 0.02% |